PharmaCyte Biotech Overview

PharmaCyte Biotech Selling, General & Admin

Selling, General & Admin expenses for PMCB.

Quarterly SG&A Expenses

$2.02M

↑ 232.41% YoY

As of Jan 31, 2026

Annual SG&A Expenses (TTM)

$5.83M

↑ 201.71% YoY

Trailing 12 months ending Jan 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin